Document type: drug_safety_update
There are 863 pages with document type ‘drug_safety_update’ in the GOV.UK search index.
Rendering apps
This document type is rendered by:
Supertypes
| Type | Group |
|---|---|
| User journey | thing |
| Email document type | other |
| Government document type | other |
| Content Purpose Subgroup | updates_and_alerts |
| Content Purpose Supergroup | news_and_communications |
Content schemas
This document type is allowed by the schema:
Example pages
- Finasteride and Dutasteride – updated safety warnings for psychiatric side effects and sexual dysfunction
- Amiodarone: reminder of risks of treatment and need for patient monitoring and supervision
- Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphylaxis with overuse
- Rybelsus ® (semaglutide tablets): transition to new formulation and risk of medication error
- GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse
- Metformin and reduced vitamin B12 levels: new advice for monitoring patients at risk
- Methotrexate: advise patients to take precautions in the sun to avoid photosensitivity reactions
- Quinine: not to be used routinely for nocturnal leg cramps
- Pregabalin (Lyrica): reports of severe respiratory depression
- Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)